Vetter is further expanding its production capacity and services at its Rankweil, Austria site.
Cagkan - stock.adobe.com
Global contract development and manufacturing organization, Vetter, has announced its plans to further expand its production capacity and services at its Rankweil, Austria site, in response to increased market demand.
According to a May 9, 2023 press release, the company will be implementing additional equipment for aseptic production and will be expanding the storage capacity at the clinical site based in Austria. A second autoclave and washing machine for material preparation will be implemented to expand cleanroom utilization. Additional freezers are also being purchased to improve cold storage capacity.
Further, Vetter will also be able to process powdered substances at the Rankweil site thanks to the implementation of an isolator, and the clinical filling portfolio is set to be expanded with a greater number of options for primary packaging materials. With these plans for expansion, the company believes that it will be able to increase the production volume of the facility by more than double in 2023 when compared with 2022.
“In addition to our existing clinical manufacturing facility in Chicago, Rankweil has established itself in a very short time as a strategically important location for us and our partners,” said Claus Feussner, senior vice-president, Vetter Development Service, in the press release. “Customer service, efficient processes, and our high-quality standard are the focus.”
Source: Vetter
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
INTERPHEX 2025: Use of Walk-In Chambers for Bio/Pharma Development and Manufacturing
April 2nd 2025Sitting down with the PharmTech Group at INTERPHEX 2025, Christopher Murphy, director of Global Business Development and Service Customer Support at Environmental Specialties, discusses the design and critical role of walk-in chambers in the bio/pharmaceutical industry.